Cornea, Cataract and Refractive Surgery Unit, Department of Ophthalmology, Hospital Quironsalud Marbella, Spain.
Clinical research fellow at VISSUM Instituto Oftalmológico de Alicante, Alicante, Spain.
Eur J Ophthalmol. 2024 Sep;34(5):1365-1372. doi: 10.1177/11206721231199780. Epub 2023 Sep 3.
Both the anterior chamber and posterior chamber phakic intraocular lenses (pIOLs) implantation are acceptable refractive surgical approaches in keratoconus patients with high anisometropia, contact lens intolerance, or who prefer spectacle and contact lens independent. They are beneficial for correcting anisometropia in stable keratoconus cases or following corneal procedures such as intrastromal corneal ring segments (ICRS), collagen cross-linking (CXL), and keratoplasty. They are suitable for eyes without advanced keratoconus with acceptable best-corrected distance visual acuity (BCDVA) or without highly irregular astigmatism, high comma, and higher-order aberrations (HOAs). Combined procedures for irregular astigmatism reduction and corneal regularization with either ICRS or topography/wavefront-guided transepithelial PRK (with or without CXL) can be associated in advance with pIOLs implantation to improve BCDVA in these cases.
To study and report the evidence regarding the safety and efficacy of pIOLs for KC patients' visual and refractive rehabilitation, we have analyzed the scientific evidence published within the last 10 years (from 2012 onwards).
No randomized controlled trials but only eleven retrospective case series and two prospective case series were identified. Satisfactory visual rehabilitation was achieved regarding uncorrected and corrected distance visual acuity (CDVA) and predictability of the refractive correction. Both types of pIOL (iris claw and posterior chamber pIOLs) offer very good results in terms of safety and efficacy with indexes close to or even exceeding 1.
pIOLs implantation is a valid refractive therapeutic approach for correcting stable keratoconus with moderate-to-high refractive errors, especially anisometropia associated with regular or mildly irregular astigmatism, and good CDVA.
对于高度屈光不正、接触镜不耐受或希望不戴眼镜和接触镜的圆锥角膜患者,前房和后房有晶状体眼人工晶状体(pIOL)植入都是可接受的屈光手术方法。它们有利于矫正稳定圆锥角膜病例的屈光不正,或在角膜基质环段(ICRS)、胶原交联(CXL)和角膜移植等角膜手术后矫正。它们适用于没有进展性圆锥角膜、可接受的最佳矫正远视力(BCDVA)或没有高度不规则散光、高彗差和高阶像差(HOAs)的眼睛。通过 ICRS 或地形图/波前引导的经上皮 PRK(联合或不联合 CXL)联合进行不规则散光矫正和角膜规则化的联合手术,可提前与 pIOL 植入联合,以提高这些病例的 BCDVA。
为了研究和报告 pIOL 用于 KC 患者视觉和屈光矫正的安全性和有效性的证据,我们分析了过去 10 年(2012 年以来)发表的科学证据。
未发现随机对照试验,仅发现 11 项回顾性病例系列研究和 2 项前瞻性病例系列研究。在未矫正和矫正远视力(CDVA)以及屈光矫正的可预测性方面,均获得了满意的视觉康复。两种类型的 pIOL(虹膜夹和后房型 pIOL)在安全性和有效性方面都提供了非常好的结果,其指标接近甚至超过 1。
pIOL 植入是一种有效的屈光治疗方法,可用于矫正中高度屈光不正的稳定圆锥角膜,尤其是与规则或轻度不规则散光相关的高度屈光不正,并且具有良好的 CDVA。